WHO Coronavirus (COVID-19) Dashboard. World Health Organization. https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&gclid=Cj0KCQjwr4eYBhDrARIsANPywCjfekv7dkHdZ6IwpwelpVAOyNT9n8cjPLGW47OL_PqcoHWcW2je4IsaAv6dEALw_wcB. Date accessed: 25 August 2023.
Centre for Health Protection, Department of Health, The Government of the Hong Kong Special Administrative Region. Latest situation of cases of COVID-19. https://chp-dashboard.geodata.gov.hk/covid-19/en.html. Date accessed: 12 April 2023.
Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–58.
Trinkmann F, Müller M, Reif A, Kahn N, Kreuter M, Trudzinski F, et al. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 Infection. Eur Respir J. 2021;57(2):2003002.
Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747–54.
Huang L, Li X, Gu X, Zhang H, Ren L, Guo L et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022:S2213-2600(22)00126-6.
Lorent N, Vande Weygaerde Y, Claeys E, Guler Caamano Fajardo I, De Vos N, De Wever W, et al. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res. 2022;8(2):00004–2022.
Faverio P, Luppi F, Rebora P, D’Andrea G, Stainer A, Busnelli S, et al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. Respir Res. 2022;23(1):65.
Marando M, Fusi-Schmidhauser T, Tamburello A, Grazioli Gauthier L, Rigamonti E, Argentieri G, et al. 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 Pneumonia – A prospective observational study. NPJ Prim Care Respir Med. 2022;32(1):8.
Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Glösenkamp C, et al. Severity of Respiratory Failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after Infection with SARS-CoV-2: an observational longitudinal study over 12 months. Respir Med. 2022;191:106709.
Shah AS, Ryu MH, Hague CJ, Murphy DT, Johnston JC, Ryerson CJ, et al. Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study. ERJ Open Res. 2021;7(3):00243–2021.
Hui DSC, Zumla A. Severe Acute Respiratory Syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869–89.
Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128(4):2247–61.
Lui GC, Yip TC, Wong VW, Chow VC, Ho TH, Li TC, et al. Significantly lower case-fatality ratio of Coronavirus Disease 2019 (COVID-19) than severe Acute Respiratory Syndrome (SARS) in Hong Kong-A territory-wide Cohort Study. Clin Infect Dis. 2021;72(10):e466–75.
Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543–50.
Li TS, Gomersall CD, Joynt GM, Chan DP, Leung P, Hui DS. Long-term outcome of acute respiratory distress syndrome caused by severe acute respiratory syndrome (SARS): an observational study. Crit Care Resusc. 2006;8(4):302–8.
Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401–9.
American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107–36.
Lung function testing. Selection of reference values and interpretative strategies. American thoracic society. Am Rev Respir Dis. 1991;144(5):1202–18.
McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40–66.
Ip MS, Ko FW, Lau AC, Yu WC, Tang KS, Choo K, et al. Hong Kong Thoracic Society and American College of Chest Physicians (Hong Kong and Macau chapter). Updated spirometric reference values for adult Chinese in Hong Kong and implications on clinical utilization. Chest. 2006;129(2):384–92.
Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1384–7.
Lam CL, Tse EY, Gandek B, Fong DY. The SF-36 summary scales were valid, reliable, and equivalent in a Chinese population. J Clin Epidemiol. 2005;58(8):815–22.
Wong CKH, Mulhern B, Cheng GHL, Lam CLK. Population based norming of the Chinese (HK) version of the SF 36 health survey. Hong Kong Practitioner. 1999;21:460–70.
Antonio GE, Wong KT, Hui DS, et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology. 2003;228(3):810–5.
Chang YC, Yu CJ, Chang SC, et al. Pulmonary sequelae in convalescent patients after severe acute respiratory syndrome: evaluation with thin-section CT. Radiology. 2005;236(3):1067–75.
Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 Novel Coronavirus (2019-nCoV). Radiology. 2020;295(1):202–7.
Pan F, Ye T, Sun P, et al. Time Course of Lung Changes at chest CT during recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 202;295(3):715–21.
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008;246(3):697–722.
World Health Organization. Clinical management of COVID-19 patients: living guidance 25 January 2021: v0.16. https://apps.who.int/iris/handle/10665/338882. Date accessed: 12 April 2023.
Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57(4):2003690.
González J, Benítez ID, Carmona P, Santisteve S, Monge A, Moncusí-Moix A, et al. CIBERESUCICOVID Project (COV20/00110, ISCIII). Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-Month prospective cohort. Chest. 2021;160(1):187–98.
Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of the COVID-19 Infection: comparison of the initial and follow-up changes. Invest Radiol. 2020;55(6):332–9.
Han X, Cao Y, Jiang N, Chen Y, Alwalid O, Zhang X, et al. Novel coronavirus Disease 2019 (COVID-19) Pneumonia progression course in 17 discharged patients: comparison of clinical and thin-section computed Tomography features during recovery. Clin Infect Dis. 2020;71(15):723–31.
Luger AK, Sonnweber T, Gruber L, Schwabl C, Cima K, Tymoszuk P, et al. Chest CT of Lung Injury 1 year after COVID-19 Pneumonia: the CovILD Study. Radiology. 2022;304(2):462–70.
Orzes N, Pini L, Levi G, Uccelli S, Cettolo F, Tantucci C. A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 Pneumonia. Respir Med. 2021;186:106541.
Lerum TV, Meltzer C, Rodriguez JR, Aaløkken TM, Brønstad E, Aarli BB et al. A prospective study of pulmonary outcomes and chest CT the first year after COVID-19. ERJ Open Res. 2022:00575–2022.
Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. Eur Respir J. 2021;58(2):2100870.
Jahn K, Sava M, Sommer G, Schumann DM, Bassetti S, Siegemund M, et al. Exercise capacity impairment after COVID-19 Pneumonia is mainly caused by deconditioning. Eur Respir J. 2021;59(1):2101136.
Ong KC, Ng AW, Lee LS, Kaw G, Kwek SK, Leow MK. e tal. Pulmonary function and exercise capacity in survivors of severe acute respiratory syndrome. Eur Respir J. 2004;24(3):436 – 42.
Wageck B, Cox NS, Holland AE. Recovery following Acute exacerbations of Chronic Obstructive Pulmonary Disease – A Review. COPD. 2019;16(1):93–103.
Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, et al. Impact of COVID-19 on people with Asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res. 2022;9(1):e001056.
Chinna K, Sundarasen S, Khoshaim HB, Kamaludin K, Nurunnabi M, Baloch GM, et al. Psychological impact of COVID-19 and lock down measures: an online cross-sectional multicounty study on Asian university students. PLoS ONE. 2021;16(8):e0253059.
Dratva J, Zysset A, Schlatter N, von Wyl A, Huber M, Volken T. Swiss University Students’ risk perception and general anxiety during the COVID-19 pandemic. Int J Environ Res Public Health. 2020;17(20):7433.
Matheson AM, McIntosh MJ, Kooner HK, Abdelrazek M, Albert MS, Dhaliwal I, et al. Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities. Thorax. 2023;78(4):418–21.
Li J, Zheng Y, Zhao L, Yue Z, Pan F, Chen Y, et al. Investigation of the impact of SARS-CoV Infection on the immunologic status and lung function after 15 years. BMC Infect Dis. 2021;21(1):1183.
Han X, Fan Y, Alwalid O, Li N, Jia X, Yuan M, et al. Six-month follow-up chest CT findings after severe COVID-19 Pneumonia. Radiology. 2021;299(1):E177–86.
Wong KT, Antonio GE, Hui DS, Ho C, Chan PN, Ng WH, et al. Severe acute respiratory syndrome: thin-section computed tomography features, temporal changes, and clinicoradiologic correlation during the convalescent period. J Comput Assist Tomogr. 2004;28(6):790–5.
Add Comment